Q3 2024 Inspire Medical Systems Inc Earnings Call Transcript

Nov 4, 2024 / 10:00 PM GMT

Release Date Price: $192.71 (+1.05%)

Transcript 10-Q8-K

Key Points

Positve

Inspire Medical Systems Inc (INSP) reported a 33% increase in revenue for Q3 2024 compared to the same period in 2023, indicating strong business performance.
The company has expanded its market presence by adding 66 new centers and 13 new U.S. sales territories, enhancing its reach and potential for growth.
Inspire Medical Systems Inc (INSP) has increased its 2024 revenue guidance to $793 to $798 million, reflecting confidence in continued growth.
The company achieved a net income of $18.5 million in Q3 2024, a significant improvement from a net loss of $8.5 million in the prior year period.
Inspire Medical Systems Inc (INSP) is advancing its product development with the soft launch of the new Sleep Sync programming system and the upcoming launch of the Inspire 5 neurostimulation system, which is expected to improve patient management and reduce production costs.

Negative

The company faces potential revenue headwinds in Q4 2024 due to hurricanes and an IV solution shortage, which could impact financial performance.
Operating expenses increased by 10% in Q3 2024 compared to the same period in 2023, primarily due to sales organization expansion and increased corporate costs.
There is uncertainty regarding the impact of GLP-1 drugs on the market, which could affect the demand for Inspire therapy.
The company needs to navigate coding strategies for the Inspire 5 system to ensure reimbursement rates remain favorable for physicians.
Inspire Medical Systems Inc (INSP) is still working on quantifying the impact of regional disruptions, such as hurricanes, on its operations and revenue.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

INSP.N - Inspire Medical Systems Inc
Q3 2024 Inspire Medical Systems Inc Earnings Call
Nov 04, 2024 / 10:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified Speaker [1]
--------------------------------------------------------------------------------
And the the two, we do see it. Okay. The the thing. Good afternoon. My name is Natasha Lamb, and I'll be your conference operator today. At this time, I'd like to welcome everyone to the Inspire Medical Systems Third Quarter 2024 conference call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question and answer session. I'll now hand the call over to your first speaker SKU. Yeah, the Vice President of Investor Relations at Inspire. You may begin the conference. Thank you, Caroline, and thank you all for participating in today's call. Joining me are Tim Herbert, Chairman and Chief Executive Officer, and Vicki Holt, Chief Financial Officer. Earlier

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.